Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma.
- Published in:
- Molecular & Cellular Oncology, 2023, v. 10, n. 1, p. 1, doi. 10.1080/23723556.2023.2238873
- By:
- Publication type:
- Article